Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 337–360 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Healthy
Interventions: SAAGE-designed, visual memory-based cognitive training; Behavioral
Lead sponsor: Posit Science Corporation; Industry
Eligibility: 60 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: San Francisco Bay Area, California

Conditions: Metabolic-dysfunction Associated Liver Disease (MASLD)
Interventions: Healthy Liver/Hígado Sano program, Usual Care; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cognitive Dysfunction
Interventions: standard Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB), enhanced Community-Friendly Health Recovery Program- Biobehavioral (CHRP-BB); Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Alzheimer Disease, Cognitive Dysfunction, Dementia
Interventions: JNJ-63733657, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 523 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 55
States / cities: Birmingham, Alabama • Phoenix, Arizona • Irvine, California + 47 more

Conditions: Alzheimer Disease, Cognitive Change, Cognitive Impairment
Interventions: BUD1, BUD2, TDD1, TDD2, CSA10, CSA20, CSA30, CSA40; Behavioral
Lead sponsor: Clemson University; Other
Eligibility: 55 Years to 85 Years
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Seneca, South Carolina

Conditions: Post-acute Sequelae of COVID-19, Depressive Symptoms, Cognitive Dysfunction
Interventions: CI-581a, CI-581b; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Mild Cognitive Impairment
Interventions: No intervention is part of this study but patients use an EEG device during observational data collection.; Device
Lead sponsor: VA Boston Healthcare System; Federal
Eligibility: 50 Years to 100 Years
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Jamaica Plain, Massachusetts

Conditions: Mild Cognitive Impairment
Interventions: Daily Enhancement Meaningful Activity (DEMA), Information Support (IS); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 21 Years to 95 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Alzheimer Disease, Dementia, Caregiver Burnout, Quality of Life, Mental Health Wellness 1, Loneliness, Family Relationship
Interventions: Virtual Reality, Video Chat; Behavioral
Lead sponsor: University of California, Santa Barbara; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 27
States / cities: Calabasas, California • Camarillo, California • Goleta, California + 16 more

Conditions: Endothelial Dysfunction, Hemolysis Intravascular, Cardiovascular Diseases, Cardiovascular Risk Factor
Interventions: Nitric Oxide, Reactive Hyperemia Index, Endothelial Cells Collection; Drug · Diagnostic Test · Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Insulin LISPRO; Drug
Lead sponsor: Louisiana State University Health Sciences Center Shreveport; Other
Eligibility: 50 Years to 95 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Shreveport, Louisiana

Conditions: Critical Illness, COVID-19, PICS, Cognitive Impairment, Mental Health Impairment, Weakness, Muscle, Dysbiosis
Interventions: Fermented Food Diet; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Meibomian Gland Dysfunction
Interventions: Blephamide, GenTeal PM Night-Time, Meibomian Gland Probing, Sham Meibomian Gland Probing; Drug · Procedure
Lead sponsor: Joseph B. Ciolino, MD; Other
Eligibility: 18 Years to 89 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Depression, Dementia, Mild Cognitive Impairment, Treatment Resistant Depression, Major Depressive Disorder, Treatment-Refractory Depression, Late Life Depression, Geriatric Depression
Interventions: Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion, Lithium Augmentation, Switch to nortriptyline; Drug
Lead sponsor: Centre for Addiction and Mental Health; Other
Eligibility: 60 Years and older
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 3
States / cities: Los Angeles, California • St Louis, Missouri • New York, New York

Conditions: Pelvic Organ Prolapse
Interventions: Restorelle Direct Fix A, Restorelle Direct Fix P, Native Tissue Repair Anterior, Native Tissue Repair Posterior; Device · Procedure
Lead sponsor: Coloplast A/S; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 810 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 33
States / cities: Agoura Hills, California • Stanford, California • Denver, Colorado + 30 more

Conditions: Atrial Fibrillation, Mild Cognitive Impairment, Dementia
Interventions: Not listed
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: 50 Years to 75 Years
Enrollment: 888 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2022
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Congestive Heart Failure, LV Dysfunction
Interventions: Dual Site LV Pacing, BiV Pacing; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Lake Geneva, Wisconsin • Milwaukee, Wisconsin

Conditions: Stress, Cognitive Change, Breast Cancer, Breast Carcinoma, Breast Neoplasm, Cognitive Dysfunction
Interventions: Mobile Daily Diary; Behavioral
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 40 Years and older · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Heart Failure, Cognitive Impairment
Interventions: Angiotensin-(1-7), Memory Training; Drug · Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 55 Years to 75 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Gait Disorder, Sensorimotor, Cognitive Disorder
Interventions: motor skill gait exercise, aerobic gait intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alzheimer Disease
Interventions: Self-Guided Lifestyle Intervention, Structured Lifestyle Intervention; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 60 Years to 79 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 6
States / cities: Sacramento, California • Chicago, Illinois • Downers Grove, Illinois + 3 more

Conditions: Graft vs Host Disease, Sjogren's Syndrome
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Erectile Dysfunction, Sexual Dysfunction, Physiological
Interventions: ARIES (Extracorporal Shock Wave Application); Device
Lead sponsor: Dornier MedTech Systems; Industry
Eligibility: 21 Years to 75 Years · Male only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Diego, California

Conditions: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Sleep study-guided adjustment of NIV, Standard initiation of NIV; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Behavioral and Physiological Effects of Visual Training

Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease

Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Elucidating the Necessary Active Components of Training

Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot Trial

Diagnosis of Alzheimer's Disease Using Event Related Potentials

Meaningful Activity Intervention for Persons With Mild Cognitive Impairment

Technology and Family Thriving Study

Effects of Nitric Oxide on the Endothelium During Hemolysis.

Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease

A Study of Healthy Microbiome, Healthy Mind

Intraductal Meibomian Gland Probing Trial

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

Restorelle® Mesh Versus Native Tissue Repair for Prolapse

Cognitive Impairment in Atrial Fibrillation

Dual Site Left Ventricular (LV) Pacing

Surviving Daily Life

Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients

Thinking, Walking Outcomes by Type of Exercise

U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk

Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells

ARIES for Vasculogenic Erectile Dysfunction

Polysomnography-directed Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)